Skip to main content

Table 3 Differences between patients and physicians perceptions

From: Reassessing the approach to informed consent: the case of unrelated hematopoietic stem cell transplantation in adult thalassemia patients

  Physicians (N = 12) mean (SE) Patients (N = 25) mean (SE) p value
Transplant-related mortality risk perception 4,9 3.6 0,001*
(1 to 7 Likert Scale) (0,3) (0.2)
Percent value of mortality risk communicated and recalled 30.0 20.4 0,005*
(% value from 5% to 50%) (2.6) (1.4)
Percent value of mortality risk considered acceptable to undergo the transplant procedure 19.6 29.6 0,005*
(% value from 5% to 50%) (2.5) (2.2)
Perception of GVHD as a severe life-threatening condition 5.4 4.1 0,006*
(1 to 7 Likert Scale) (0.4) (0.2)
How much previous information had influenced the patient before informed consent 4.6 2.2 0,006*
(1 to 7 Likert Scale) (0.4) (0.3)
Motivation to undergo HSCT before informed consent 4.6 4.8 NS
(1 to 7 Likert Scale) (0.5) (0.3)
  1. *Two-tailed t test significant value; GVHD: Graft Versus Host Disease; SE: standard error.